Page last updated: 2024-11-02

oxaprozin and Stevens-Johnson Syndrome

oxaprozin has been researched along with Stevens-Johnson Syndrome in 2 studies

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research Excerpts

ExcerptRelevanceReference
"We describe a case of Stevens-Johnson syndrome (SJS) associated with oxaprozin ("Daypro"), a relatively new nonsteroidal antiinflammatory drug (NSAID) of the propionic acid group."7.70A case of Stevens-Johnson syndrome associated with oxaprozin therapy. ( Bell, MJ; Bishara, LD, 1998)
"We describe a case of Stevens-Johnson syndrome (SJS) associated with oxaprozin ("Daypro"), a relatively new nonsteroidal antiinflammatory drug (NSAID) of the propionic acid group."3.70A case of Stevens-Johnson syndrome associated with oxaprozin therapy. ( Bell, MJ; Bishara, LD, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, MJ1
Bishara, LD1
Carucci, JA1
Cohen, DE1

Other Studies

2 other studies available for oxaprozin and Stevens-Johnson Syndrome

ArticleYear
A case of Stevens-Johnson syndrome associated with oxaprozin therapy.
    The Journal of rheumatology, 1998, Volume: 25, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Middle Aged; Oxaproz

1998
Toxic epidermal necrolysis following treatment with oxaprozin.
    International journal of dermatology, 1999, Volume: 38, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Humans; Male; Oxaprozin; Propionates;

1999